← Back to Search

Other

Medium or High Nicotine for Nicotine Addiction

N/A

Waitlist Available

Led By Neal Benowitz, MD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up days 1-3 of each arm

Awards & highlights

Study Summary

This trial will study the effects of different nicotine levels in e-cigarettes on users' nicotine intake, exposure to harmful chemicals, and short-term cardiovascular health.

Eligible Conditions

Nicotine Addiction
Cardiovascular Risk

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ days 1-3 of each arm

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~days 1-3 of each arm

This trial's timeline: 3 weeks for screening, Varies for treatment, and days 1-3 of each arm for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Cardiovascular Effects: Diastolic Blood Pressure

Cardiovascular Effects: Heart Rate

Cardiovascular Effects: Systolic Blood Pressure

+1 more

Secondary outcome measures

Vaping Topography: Inter-Puff Interval

Vaping Topography: Puff Duration

Vaping Topography: Puff Number

Trial Design

2Treatment groups

Experimental Treatment

Group I: Medium or High NicotineExperimental Treatment1 Intervention

The patient will participate in a standardized vaping session using either an electronic cigarette with 18 mg/ml nicotine e-liquid or a JUUL device with a JUUL e-liquid pod.

Group II: Low NicotineExperimental Treatment1 Intervention

Using an electronic cigarette, the patient will participate in a standardized vaping session using 3 mg/ml nicotine e-liquid.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor

2,505 Previous Clinical Trials

15,237,555 Total Patients Enrolled

2 Trials studying Nicotine Addiction

991 Patients Enrolled for Nicotine Addiction

National Institute on Drug Abuse (NIDA)NIH

2,467 Previous Clinical Trials

2,619,123 Total Patients Enrolled

15 Trials studying Nicotine Addiction

2,130 Patients Enrolled for Nicotine Addiction

Neal Benowitz, MDPrincipal InvestigatorUniversity of California, San Francisco

2 Previous Clinical Trials

38 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical research include participants who are 45 or older?

"Aged between 21 and 70, participants are invited to join this medical trial."

Answered by AI

Am I qualified to participate in this research project?

"To be eligible to enroll in this trial, the patient must have a diagnosis of tobacco dependence and fall within the age range of 21-70. The total number of participants desired is 36 individuals."

Answered by AI

Are there any open slots for participants in this clinical experiment?

"At the present time, this clinical trial is not currently accepting participants. The research was first advertised on June 1st, 2023 and has since been updated as of September 1st, 2021. While this experiment does not have active recruitment at the moment, there are 189 other trials that do require volunteers for their studies."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Vaping High vs. Low Nicotine E-Liquid

2023. "Vaping High vs. Low Nicotine E-Liquid". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04047836.